1218.75.050 Boehringer Ingelheim Investigational Site — Memphis, Tennessee

1218.75.050 Boehringer Ingelheim Investigational Site is a clinical research site located in Memphis, Tennessee, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

1218.75.050 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 1218.75.050 Boehringer Ingelheim Investigational Site?

1218.75.050 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 1218.75.050 Boehringer Ingelheim Investigational Site conducted?

1218.75.050 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is 1218.75.050 Boehringer Ingelheim Investigational Site accredited by Crixeo Health?

1218.75.050 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 1218.75.050 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.